TABLE 2

SUV_peak for All Lesions and Time Points After First and Second mAb Administrations

	First mAb administration			Second mAb administration
Parameter	First time point	Second time point	Third time point	First time point	Second time point
Patient 1
Hours after injection	2	48	119	49	117
SUV_peak
Bone lesion	BLQ	2.49	3.12	2.30	2.90
Bone lesion	4.19	4.55	2.60	4.80	3.51
Soft-tissue lesion	6.47	5.42	3.14	4.59	3.53
Soft-tissue lesion	2.26	4.53	3.60	4.87	3.10
Bone lesion	4.32	5.64	3.88	6.90	5.95
Bone lesion	3.36	3.23	2.89	3.36	2.96
Patient 2
Hours after injection	2	46	115	44	118
SUV_peak, lung lesion	2.22	1.87	1.57	1.71	1.57
Patient 3
Hours after injection	2	50	116	49	139
SUV_peak
Lung lesion	BLQ	2.19	1.26	3.59	3.78
Bone lesion	BLQ	3.92	4.83	2.85	3.13
Bone lesion	BLQ	5.30	5.87	5.78	6.20
Bone lesion	BLQ	5.45	6.12	5.49	4.87
Patient 4
Hours after injection	2	51	116	45	115
SUV_peak, soft-tissue lesion	NA	9.94	12.01	5.72	5.92
Patient 5
Hours after injection	2	42	138	40	113
SUV_peak
Lymph node lesion	NA	3.69	3.84	3.11	3.97
Bone lesion		15.66	15.26	6.58	11.23
Lymph node lesion		4.45	4.34	3.32	3.95
Lymph node lesion		3.96	4.06	2.72	2.92
Lymph node lesion		3.22	2.64	4.22	3.41
Lymph node lesion		4.60	5.38	4.50	5.71

BLQ = below limit of quantification; NA = not applicable.